<?xml version="1.0" encoding="UTF-8"?>
<p>Gastrointestinal symptoms, especially diarrhea, are common in MERS‐CoV infections and occur in up to at least one‐third of patients.
 <xref rid="jmv26066-bib-0122" ref-type="ref">
  <sup>122</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0126" ref-type="ref">
  <sup>126</sup>
 </xref> What has been somewhat more important in this context, however, is that asymptomatic or relatively minor infections occur in a considerable number of people who test positive with genetic amplification technologies.
 <xref rid="jmv26066-bib-0127" ref-type="ref">
  <sup>127</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0129" ref-type="ref">
  <sup>129</sup>
 </xref> One review proposed that some 12% to 25% of identified MERS‐CoV infections are asymptomatic.
 <xref rid="jmv26066-bib-0130" ref-type="ref">
  <sup>130</sup>
 </xref> These findings also need to be couched in the context of potential test fallibility for a variety of reasons.
 <xref rid="jmv26066-bib-0131" ref-type="ref">
  <sup>131</sup>
 </xref>
</p>
